Here are four things to know about the aborted deal.
1. The organizations signed an asset purchase agreement in December 2017, and had expected to complete the due diligence process within six months.
2. Under the deal, Bellin Health Systems agreed to purchase DHCS for about $40 million to $50 million. But DCHS officials said the health system incurred unpredicted losses, driving up the asset purchase price, according to the report.
3. The health systems reached out to the state of Michigan for financial assistance to complete the deal but the state declined to help DCHS.
4. Bellin Health Systems and DCHS will continue to discuss other initiatives to build on their relationship and provide services to the community, the report states.
More articles on transactions and valuations:
6 recent healthcare partnerships and transactions
District to seek bids to reopen shuttered Tulare Regional weeks after FBI raids ex-CEO’s home
Tenet’s Detroit Medical Center to sell outpatient pharmacy business to Walgreens
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
